DI PASQUALE, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 972
EU - Europa 418
AS - Asia 128
AF - Africa 14
SA - Sud America 11
Totale 1.543
Nazione #
US - Stati Uniti d'America 963
IT - Italia 184
UA - Ucraina 57
SG - Singapore 51
IN - India 45
SE - Svezia 31
DE - Germania 26
CN - Cina 22
BG - Bulgaria 19
FI - Finlandia 18
CH - Svizzera 14
AT - Austria 13
FR - Francia 12
IE - Irlanda 10
TG - Togo 10
GB - Regno Unito 8
NL - Olanda 8
CA - Canada 7
AR - Argentina 6
HK - Hong Kong 4
RO - Romania 4
SC - Seychelles 4
MK - Macedonia 3
PE - Perù 3
AL - Albania 2
HU - Ungheria 2
MX - Messico 2
TR - Turchia 2
BE - Belgio 1
BR - Brasile 1
CO - Colombia 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
LU - Lussemburgo 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
VN - Vietnam 1
Totale 1.543
Città #
Fairfield 130
Chandler 89
Ashburn 83
Woodbridge 75
Seattle 54
Houston 52
Cambridge 50
Wilmington 44
Rome 43
Dearborn 37
Singapore 35
New York 26
Princeton 23
Sofia 19
Ann Arbor 17
San Paolo di Civitate 16
Milan 14
Plano 14
Lawrence 13
Boston 11
Millbury 11
Vienna 11
Bremen 10
Dublin 10
Lomé 10
San Diego 10
Santa Clara 10
Andover 7
Beijing 7
Fremont 7
Helsinki 7
Boardman 6
Federal 6
Ponzano Veneto 6
Rotterdam 6
Bari 5
Naples 5
Toronto 5
Hong Kong 4
Jacksonville 4
Paris 4
San Mateo 4
Turin 4
Buffalo 3
Bühl 3
Chicago 3
Des Moines 3
Frankfurt am Main 3
Guangzhou 3
Lima region 3
Mahé 3
Bengaluru 2
Bouc-Bel-Air 2
Cascina 2
Cincinnati 2
Fasano 2
Florence 2
Istanbul 2
Kunming 2
La Spezia 2
Limoges 2
Los Angeles 2
Mannheim 2
Mexico City 2
Napoli 2
Newham 2
Norwalk 2
Ottawa 2
Pisa 2
Pune 2
Saint-Fons 2
San Jose 2
Seregno 2
Struga 2
Tirana 2
Vicenza 2
Xian 2
Zurich 2
Ancona 1
Aprilia 1
Atlanta 1
Barcelona 1
Belgrade 1
Boisar 1
Boulder 1
Brasília 1
Brussels 1
Budapest 1
Clifton 1
Council Bluffs 1
Dallas 1
Davis 1
Falls Church 1
Formello 1
Grafing 1
Guiyang 1
Hanoi 1
Hefei 1
Hyderabad 1
Inzago 1
Totale 1.104
Nome #
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab 162
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study 142
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 90
Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity 86
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis 85
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 84
Nerve high resolution ultrasonography in Tangier disease 82
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre 81
Hypogonadism in DM1 and its relationship to erectile dysfunction 80
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 80
Erectile dysfunction in Myotonic Dystrophy type 1 (DM1) 77
Magnetic resonance imaging contribution for diagnosing symptomatic neurovascular contact in classical trigeminal neuralgia: A blinded case-control study and meta-analysis 69
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 68
Ultrasound as a useful tool in the diagnosis and management of traumatic nerve lesions 66
Seropositive myasthenia gravis (MG): is there a changing trend in the age at onset? 59
Thalidomide-associated neuropathy in multiple myeloma 58
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 57
Intracellular insulin mediated signalling in Myotonic Dystrophy type 1 (DM1) 48
Short-term memory test in DM1 and correlations with regional cortical atrophy. 5th international myotonic dystrophy 43
Intracellular insulin mediated signaling in myotonic dystrophy type 1 43
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 38
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 19
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis. A subgroup analysis of the REGAIN open-label extension study 14
null 4
Totale 1.635
Categoria #
all - tutte 4.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 5 16 34 57 52 34 33 17 18 18
2020/2021203 18 15 13 17 6 28 6 10 32 29 19 10
2021/2022259 7 13 27 10 31 8 4 27 15 13 61 43
2022/2023298 44 56 13 54 37 23 10 10 29 3 12 7
2023/2024255 10 26 8 17 17 60 7 32 8 28 15 27
2024/202576 17 47 12 0 0 0 0 0 0 0 0 0
Totale 1.635